Q3 2019 Aldeyra Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Aldeyra Therapeutics Third Quarter 2019 Financial Results Conference Call. My name is Andrea, and I will be your operator today. (Operator Instructions) At this time, I would like to turn the call over to Mr. Joshua Reed, the company's Chief Financial Officer. Please go ahead, sir.
Good morning, everyone. With me today is Dr. Todd Brady, Chief Executive Officer. Todd will begin today's call with an overview of our strategy and recent highlights. I will discuss our Q3 results. Todd will make some concluding comments, and then we will be happy to take your questions.
Please note that this morning's conference call contains forward-looking statements regarding future events and the future performance of Aldeyra. Forward-looking statements include statements regarding Aldeyra's possible or assumed future results of operations, expenses and financial position, business strategies and plans, research, development and commercial plans or expectations, trends, market sizing,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |